Hanson McClain Advisors »

Karyopharm Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $755 500 1.51
2023-12-31 $433 500 0.87
2023-09-30 $670 500 1.34
2023-06-30 $895 500 1.79
2023-03-31 $1.9k 500 3.89
2022-12-31 $1.7k 500 3.40
2022-09-30 $1.0k 100 10.00
2022-06-30 $0 100 0.00
2022-03-31 $1.0k 100 10.00
2021-12-31 $1.0k 100 10.00
2021-09-30 $1.0k 100 10.00
2021-06-30 $1.0k 100 10.00
2021-03-31 $5.0k 430 11.63
2020-12-31 $2.0k 100 20.00